by Nicole Jupe on May 21, 2013
The first study to obtain a detailed profile of users of synthetic cannabinoid was published in the May 20 issue of CESAR (Center for Substance Abuse Research) report.
According to this research, synthetic cannabinoid use among college students at a Southeastern university is concentrated in males and in the lesbian, gay, bisexual or transgender (LGBT) community. Students who self-identified themselves as LGBT were nearly twice as likely as heterosexual students (27 percent vs. 14 percent) to report lifetime use.
The study also found that lifetime use of synthetic cannabinoids was virtually non-existent among those who did not report past month alcohol (0.3 percent) or marijuana (0.4 percent) use, compared to 16 percent and 24 percent, respectively, of past month users of these substances.
Click here to view a PDF of the complete CESAR report.
by Nicole Jupe on April 12, 2013
Oral fluid testing was a hot topic at the Drug and Alcohol Testing Industry Association (DATIA) conference this week. Many attendees stopped by the Oral-Eze® booth with questions about collections, drug panels and federal regulations. Our team gave product demonstrations to show how the Oral-Eze window turns blue when there is a sufficient sample for testing. Oral fluid is an attractive modality because the collection is observed and simple to administer onsite. Check out the spring issue of the DATIA Focus magazine which features more information in an article Oral Fluid Collections and Considerations.
In addition, Dr. Barry Sample presented data from the Quest Diagnostics Drug Testing Index™ at this year’s conference. He noted an increase in overall positivity rates for marijuana in oral fluid versus urine testing, part of which is attributed to our new oral fluid technology and its improved ability to detect marijuana.
